Joel Lewis, President and CEO: Galectin Therapeutics GALT Sell · Filed 25/12/19

Trade details

Type: Insider sale
Amount: $55,272.74
Shares · price: 7,829 sh · $7.06 a share
Held after: 832,592 sh
Stock: Galectin Therapeutics GALT
Person: Joel LewisPresident and CEO
Trade date: 25/12/17
Filed: 25/12/19
Days to filing: 2 days

Sold 0.9% of holdings

Share of holding sold: 0.9%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/17~01/16

Joel Lewis's recent trades

Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$135K
37,698 sh
$135K
Filed 01/06
Traded 01/06
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$108.4K
27,731 sh
$108.4K
Filed 01/06
Traded 01/05
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$78K
18,571 sh
$78K
Filed 01/06
Traded 01/02
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$352.8K
84,000 sh
$352.8K
Filed 01/02
Traded 01/02
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$282.2K
40,000 sh
$282.2K
Filed 25/12/17
Traded 25/12/17